Initial C-reactive protein level: Discriminating between anti-TNF and anti-IL-17 agents as the first biologic treatment for axial spondyloarthritis?

被引:0
作者
Goupille, Philippe [1 ]
Wendling, Daniel [2 ]
机构
[1] Univ Tours, Trousseau Hosp, Rheumatol Dept, CHU Tours,EA 6295, Ave Republ, F-37044 Tours 9, France
[2] Univ Franche Comte, Rheumatol Dept, CHU Besancon, EA 4266, Besancon, France
关键词
Axial spondyloarthritis; Treatment; C-reactive protein; CLINICAL-RESPONSE; DOUBLE-BLIND; ADALIMUMAB; PREDICTORS; EFFICACY; THERAPY; SAFETY;
D O I
10.1016/j.jbspin.2023.105662
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 22 条
  • [11] Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics Register
    Lord, Paul A. C.
    Farragher, Tracey M.
    Lunt, Mark
    Watson, Kath D.
    Symmons, Deborah P. M.
    Hyrich, Kimme L.
    [J]. RHEUMATOLOGY, 2010, 49 (03) : 563 - 570
  • [12] Maksymowych W, 2020, ARTHRITIS RHEUMATOL, V72
  • [13] Ixekizumab in radiographic axial spondyloarthritis with and without elevated C-reactive protein or positive magnetic resonance imaging
    Maksymowych, Walter P.
    Bolce, Rebecca
    Gallo, Gaia
    Seem, Emily
    Geneus, Vladimir J.
    Sandoval, David M.
    Ostergaard, Mikkel
    Tada, Kurisu
    Baraliakos, Xenofon
    Deodhar, Atul
    Gensler, Lianne S.
    [J]. RHEUMATOLOGY, 2022, 61 (11) : 4324 - 4334
  • [14] Predictors of response to TNF antagonists in patients with ankylosing spondylitis and psoriatic arthritis: systematic review and meta-analysis
    Maneiro, Jose Ramon
    Souto, Alejandro
    Salgado, Eva
    Mera, Antonio
    Gomez-Reino, Juan J.
    [J]. RMD OPEN, 2015, 1 (01):
  • [15] Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration
    Ornbjerg, Lykke M.
    Linde, Louise
    Georgiadis, Stylianos
    Rasmussen, Simon H.
    Lindstrom, Ulf
    Askling, Johan
    Michelsen, Brigitte
    Di Giuseppe, Daniela
    Wallman, Johan K.
    Pavelka, Karel
    Zavada, Jakub
    Nissen, Michael J.
    Jones, Gareth T.
    Relas, Heikki
    Pirila, Laura
    Tomsic, Matija
    Rotar, Ziga
    Geirsson, Arni Jon
    Gudbjornsson, Bjorn
    Kristianslund, Eirik K.
    Horst-Bruinsma, Irene Van Sder
    Loft, Anne Gitte
    Laas, Karin
    Iannone, Florenzo
    Corrado, Addolorata
    Ciurea, Adrian
    Santos, Maria J.
    Santos, Helena
    Codreanu, Catalin
    Akkoc, Nurullah
    Gunduz, Ozgul S.
    Glintborg, Bente
    Ostergaard, Mikkel
    Hetland, Merete Lund
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2022, 56
  • [16] Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor α blockers in ankylosing spondylitis
    Rudwaleit, M
    Listing, J
    Brandt, J
    Braun, J
    Sieper, J
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (06) : 665 - 670
  • [17] Effectiveness, Safety, and Predictors of Good Clinical Response in 1250 Patients Treated with Adalimumab for Active Ankylosing Spondylitis
    Rudwaleit, Martin
    Claudepierre, Pascal
    Wordsworth, Paul
    Loza Cortina, Eduardo
    Sieper, Joachim
    Kron, Martina
    Carcereri-de-Prati, Roberto
    Kupper, Hartmut
    Kary, Sonja
    [J]. JOURNAL OF RHEUMATOLOGY, 2009, 36 (04) : 801 - 808
  • [18] A Randomized, Double-Blind, Placebo-Controlled, Sixteen-Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis
    Sieper, J.
    van der Heijde, D.
    Dougados, M.
    Maksymowych, W. P.
    Scott, B. B.
    Boice, J. A.
    Berd, Y.
    Bergman, G.
    Curtis, S.
    Tzontcheva, A.
    Huyck, S.
    Weng, H. H.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67 (10) : 2702 - 2712
  • [19] Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)
    Sieper, Joachim
    van der Heijde, Desiree
    Dougados, Maxime
    Mease, Philip J.
    Maksymowych, Walter P.
    Brown, Matthew A.
    Arora, Vipin
    Pangan, Aileen L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (06) : 815 - 822
  • [20] Predicting the outcome of ankylosing spondylitis therapy
    Vastesaeger, Nathan
    van der Heijde, Desiree
    Inman, Robert D.
    Wang, Yanxin
    Deodhar, Atul
    Hsu, Benjamin
    Rahman, Mahboob U.
    Dijkmans, Ben
    Geusens, Piet
    Vander Cruyssen, Bert
    Collantes, Eduardo
    Sieper, Joachim
    Braun, Juergen
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (06) : 973 - 981